By Frank Prenesti
Date: Wednesday 01 May 2024
(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.
The company said it now expected a rise of 8% - 10% in annual adjusted earnings per share, up from the 6% - 9%...
or login to read the full story
Email this article to a friend
or share it with one of these popular networks:
You are here: news